Immunotherapy resistance in melanoma
Ontology highlight
ABSTRACT: Clinical and Molecular Heterogeneity in Patients with Innate Resistance to Anti-PD-1 and/or Anti-CTLA-4 Immunotherapy in Metastatic Melanoma Reveals Distinct Therapeutic Targets
PROVIDER: PRJEB45846 | ENA |
REPOSITORIES: ENA
ACCESS DATA